Nanjing Hicin Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 300584.SZ

Nanjing Hicin Pharmaceutical Co., Ltd. Dividend Yield on January 27, 2025: 0.28%

Nanjing Hicin Pharmaceutical Co., Ltd. Dividend Yield is 0.28% on January 27, 2025, a 2.91% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.
  • Nanjing Hicin Pharmaceutical Co., Ltd. 52-week high Dividend Yield is 0.41% on February 07, 2024, which is 46.64% above the current Dividend Yield.
  • Nanjing Hicin Pharmaceutical Co., Ltd. 52-week low Dividend Yield is 0.21% on October 08, 2024, which is -25.44% below the current Dividend Yield.
  • Nanjing Hicin Pharmaceutical Co., Ltd. average Dividend Yield for the last 52 weeks is 0.30%.
Key data
Date Dividend Yield Free Cash Flow Yield Earnings Yield Enterprise Value (EV)
Market news
SV Wall Street
Shenzhen Stock Exchange: 300584.SZ

Nanjing Hicin Pharmaceutical Co., Ltd.

CEO Mr. Yuping Cao
IPO Date Jan. 12, 2017
Location China
Headquarters No.1 Hengfa Road
Employees 553
Sector Healthcare
Industries
Pharmaceuticals Biotechnology Cleaning Supplies Drugstores & Retail Pharmacies
Description

Nanjing Hicin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, marketing, and sale of pharmaceutical preparations and synthetic chemicals in China. The company offers antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for cardio-cerebral system, and immuno-modulate agents. It also provides technical transferring services. The company also exports APIs; omeprazole sodium and cefepime hydrochloride for injections; and lansoprazole tablets to South-Asian countries, South-American countries, and European countries. Nanjing Hicin Pharmaceutical Co., Ltd. was founded in 2003 and is based in Nanjing, China.

StockViz Staff

February 4, 2025

Any question? Send us an email